BeOne Medicines Ltd (NAS:ONC) Stock News, Headlines & Updates
BeOne Medicines Ltd Stock News from GuruFocus
- 1
- 2
Jul 10, 2025
BeOne Medicines (ONC) Gains EU Approval for Tevimbra in Cancer Therapy
GuruFocus News • 10:55am
European Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal Carcinoma
Business Wire • 6:00am
BeOne Medicines (ONC) Gains EU Approval for TEVIMBRA in Nasopharyngeal Carcinoma | ONC Stock News
GuruFocus News • 5:33am
European Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal Carcinoma | ONC Stock News
GuruFocus News • 5:17am
Jun 27, 2025
BeOne Medicines (ONC) Price Target Raised by Morgan Stanley | ONC Stock News
GuruFocus News • 11:02am
BeOne Medicines (ONC) Maintains Overweight Rating Amid Price Target Increase | ONC Stock News
GuruFocus News • 9:01am
RBC Capital Reiterates Outperform Rating for BeOne Medicines (ONC) | ONC Stock News
GuruFocus News • 8:01am
Morgan Stanley Boosts Price Target for BeOne Medicines (ONC) | ONC Stock News
GuruFocus News • 7:46am
JPMorgan Analyst Boosts Price Target for BeOne Medicines (ONC) | ONC Stock News
GuruFocus News • 6:47am
Jun 26, 2025
BeOne Medicines Ltd (ONC) Unveils Major Oncology Pipeline Advancements | ONC stock news
GuruFocus News • 6:01am
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day
Business Wire • 6:00am
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day | ONC Stock News
GuruFocus News • 5:16am
Jun 25, 2025
BeOne Medicines Ltd (ONC) Receives Positive CHMP Opinion for New BRUKINSA Tablet Formulation | ONC stock news
GuruFocus News • 6:01am
BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA®
Business Wire • 6:00am
BeOne Medicines (ONC) Advances with Positive EMA Opinion for BRUKINSA Tablets | ONC Stock News
GuruFocus News • 5:16am
BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA® | ONC Stock News
GuruFocus News • 5:15am
Jun 12, 2025
BeOne Medicines Ltd (ONC) Unveils Promising Clinical Data at EHA Congress | ONC stock news
GuruFocus News • 6:04am
BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025
Business Wire • 6:00am
BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025 | ONC Stock News
GuruFocus News • 5:16am
Jun 11, 2025
FDA Approves New Tablet Formulation of BRUKINSA by BeOne Medicines Ltd (ONC) | ONC stock news
GuruFocus News • 4:05pm
U.S. FDA Approves Tablet Formulation of BeOne's BRUKINSA® for All Approved Indications
Business Wire • 4:00pm
BeOne Medicines (ONC) Receives FDA Approval for New BRUKINSA Tablet | ONC Stock News
GuruFocus News • 3:33pm
U.S. FDA Approves Tablet Formulation of BeOne's BRUKINSA? for All Approved Indications | ONC Stock News
GuruFocus News • 3:16pm
BeOne Medicines Ltd (ONC) Announces Investor R&D Day to Showcase Global Oncology Innovations | ONC stock news
GuruFocus News • 6:06am
BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025
Business Wire • 6:00am
BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025 | ONC Stock News
GuruFocus News • 5:15am
Jun 02, 2025
BeOne Medicines Ltd (ONC) Unveils Promising Clinical Data at ASCO 2025 | ONC stock news
GuruFocus News • 6:06am
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025
Business Wire • 6:00am
BeOne Medicines (ONC) Reveals Promising Breast Cancer Treatment Data | ONC Stock News
GuruFocus News • 5:30am
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025 | ONC Stock News
GuruFocus News • 5:16am
Jun 01, 2025
BeOne Medicines (ONC) Reveals Promising SEQUOIA Trial Results | ONC Stock News
GuruFocus News • 3:15pm
May 31, 2025
BeOne Medicines Ltd (ONC) Unveils Promising Phase 3 SEQUOIA Trial Results for BRUKINSA | ONC stock news
GuruFocus News • 8:01am
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA's Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025
Business Wire • 8:00am
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA's Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025 | ONC Stock News
GuruFocus News • 7:15am
May 27, 2025
BeOne Medicines Ltd (ONC) Announces Name Change and Redomiciliation to Switzerland | ONC stock news
GuruFocus News • 8:06am
BeOne Medicines (ONC) Finalizes Rebranding and Relocation to Switzerland | ONC Stock News
GuruFocus News • 8:01am
BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology
Business Wire • 8:00am
BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology | ONC Stock News
GuruFocus News • 7:48am
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news